Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MAFLD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07637006
What this trial is testing

Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Hong Kong Baptist University 180
Not applicableStudy completedNCT06492369
What this trial is testing

MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

Who this might be right for
Metabolic- Associated Fatty Liver Disease (MAFLD)
Tanta University 382
Not applicableEnrolling By InvitationNCT05956379
What this trial is testing

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.

Who this might be right for
Chronic Hepatitis BNon-alcoholic Fatty Liver Disease
National Taiwan University Hospital 100
Very early researchStudy completedNCT04853082
What this trial is testing

Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution

Who this might be right for
Fatty Liver
Hongsheng Tan 57
Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Not applicableStudy completedNCT07548970
What this trial is testing

Identification and Characterization of At-risk MASLD in Turkish Adults

Who this might be right for
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)Mediterranean DietLifestyle (Sedentary Behavior and Physical Activity)+3 more
Maastricht University Medical Center 459
Not applicableLooking for participantsNCT07233486
What this trial is testing

A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD

Who this might be right for
MAFLD
The Affiliated Hospital of Hangzhou Normal University 2,000
Not applicableNot Yet RecruitingNCT06749704
What this trial is testing

Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Institute of Liver and Biliary Sciences, India 140
Large-scale testing (Phase 3)Active Not RecruitingNCT06884293
What this trial is testing

A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）

Who this might be right for
OverweightMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Innovent Biologics (Suzhou) Co. Ltd. 479
Not applicableStudy completedNCT07539584
What this trial is testing

Adiponectin in Patients With Metabolic Disorders

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Type 2 Diabetes Mellitus (T2DM)
Moscow Regional Research and Clinical Institute (MONIKI) 130
Not applicableNot Yet RecruitingNCT07177963
What this trial is testing

CPET-based HIIT for MAFLD

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease
Tang Yida 54
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableNot Yet RecruitingNCT06097338
What this trial is testing

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

Who this might be right for
Fatty Liver Disease, Nonalcoholic
Qianfoshan Hospital 200
Not applicableNot Yet RecruitingNCT07284004
What this trial is testing

Fatty Liver in Long Standing Cholecystectomy

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Post-cholecystectomy Metabolic Changes -Hepatic Steatosis
Yasmeen Ahmed Farrag Ahmed 100
Not applicableUnknownNCT05104541
What this trial is testing

Impact of Weight Loss in Cirrhosis With Obesity and MAFLD

Who this might be right for
Liver CirrhosisObesity
Institute of Liver and Biliary Sciences, India 96
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Post-approval studies (Phase 4)Study completedNCT05474560
What this trial is testing

Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseHyperuricemia
Ain Shams University 90
Not applicableUnknownNCT05708560
What this trial is testing

Relationship Between MAFLD and Liver Fibrosis Progression in Patients With Chronic Hepatitis B: a Multicenter Retrospective Cohort Study

Who this might be right for
Hepatitis B, Chronic
Erasmus Medical Center 800
Not applicableUnknownNCT05525884
What this trial is testing

Mechanism of Serum PRL in the Development of MAFLD

Who this might be right for
Type2 DiabetesFatty Liver, NonalcoholicLiver Fibrosis
Shen Qu 1,000
Next Page